PacBio, TychoBio Collaborate Over Generation Of RNA Data To Train Models For RNA Therapy Design

PacBio (NASDAQ: PACB) has partnered with TychoBio to generate full-length RNA data for training models aimed at RNA therapy design. TychoBio will utilize PacBio's HiFi sequencing technology to analyze over 10,000 samples, creating extensive datasets that connect the design of steric blocking antisense oligonucleotides (SBOs) to their transcriptomic effects. The collaboration may also extend to include siRNA and other RNA-targeting compounds.